Location History:
- Københaven K, DK (2020)
- København K, DK (2020 - 2021)
Company Filing History:
Years Active: 2020-2021
Title: Garry Paul Gippert - Innovator in Lipase Variants and Odor Reduction Technologies
Introduction
Garry Paul Gippert is a notable inventor based in København K, Denmark. With an impressive portfolio of 4 patents, Gippert has made significant contributions to the field of biotechnology, particularly in methods aimed at reducing odors through advanced lipase variants.
Latest Patents
Garry's recent patents center around innovative technologies for odor reduction. One of his key inventions involves a method for hydrolyzing a lipase substrate. This method entails the addition of a specific lipase variant, which boasts a high degree of sequence identity to a parent lipase. The significant characteristic of this invention is its capacity to minimize odor compared to conventional methods. Additionally, his patents include lipase variants that maintain lipase activity while having substantial modifications in their amino acid sequence. These innovations not only showcase his expertise but also contribute to developing practical applications in industries where odor control is essential.
Career Highlights
Garry Paul Gippert is currently associated with Novozymes A/S, a leading global biotechnology company known for its focus on enzyme production and biotechnological innovations. His work within this esteemed organization has enabled him to leverage cutting-edge research and development, further enhancing the impact of his inventions.
Collaborations
In his professional journey, Gippert has collaborated with several talented individuals, including Jesper Vind and Lone Baunsgaard. These partnerships have likely facilitated the advancement of his research projects and helped in the synthesis of effective solutions in odor management and biocatalysis.
Conclusion
In summary, Garry Paul Gippert stands as a pioneering inventor with a focus on reducing odors through innovative lipase technologies. His dedication to improving biotechnological methods at Novozymes A/S reflects his commitment to driving meaningful change in the industry. With his proven track record and ongoing research endeavors, Gippert's work continues to influence and inspire advancements in the realm of biotechnology.